1. Home
  2. DXPE vs OGN Comparison

DXPE vs OGN Comparison

Compare DXPE & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DXP Enterprises Inc.

DXPE

DXP Enterprises Inc.

HOLD

Current Price

$131.40

Market Cap

2.0B

Sector

Industrials

ML Signal

HOLD

Logo Organon & Co.

OGN

Organon & Co.

HOLD

Current Price

$6.35

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DXPE
OGN
Founded
1908
1923
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
1.7B
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
DXPE
OGN
Price
$131.40
$6.35
Analyst Decision
Hold
Analyst Count
0
4
Target Price
N/A
$11.75
AVG Volume (30 Days)
89.2K
3.2M
Earning Date
06-02-2026
05-14-2026
Dividend Yield
N/A
1.26%
EPS Growth
27.25
N/A
EPS
5.37
0.72
Revenue
$1,247,043,000.00
$6,216,000,000.00
Revenue This Year
$6.88
$0.42
Revenue Next Year
$7.10
$1.67
P/E Ratio
$24.26
$8.83
Revenue Growth
N/A
N/A
52 Week Low
$67.68
$6.18
52 Week High
$171.70
$15.88

Technical Indicators

Market Signals
Indicator
DXPE
OGN
Relative Strength Index (RSI) 42.05 30.98
Support Level $107.83 $6.18
Resistance Level $154.19 $7.87
Average True Range (ATR) 8.60 0.25
MACD -2.43 -0.05
Stochastic Oscillator 5.28 7.24

Price Performance

Historical Comparison
DXPE
OGN

About DXPE DXP Enterprises Inc.

DXP Enterprises Inc is engaged in the business of distributing maintenance, repair and operating (MRO) products, equipment and service to customers in various end markets, including general industrial, energy, food & beverage, chemical, transportation, water and wastewater. The company operates through three business segments: Service Centers, Innovative Pumping Solutions and Supply Chain Services. The majority of revenue is derived from the Service Centers segment, which provides a wide range of MRO products in the rotating equipment, bearing, power transmission, hose, fluid power, metal working, fastener, industrial supply, safety products and safety services categories. Geographically, it generates the maximum revenue from the United States.

About OGN Organon & Co.

Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.

Share on Social Networks: